Drug Type Chemical drugs |
Synonyms ARGININE ASPARTATE |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC10H21N5O6 |
InChIKeySUUWYOYAXFUOLX-ZBRNBAAYSA-N |
CAS Registry3054-35-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscle fatigue | Phase 1 | BR | 05 Nov 2008 | |
Periodontitis | Discovery | UA | 20 Oct 2017 |
Not Applicable | 40 | Methotrexatum | mgdsmehqch(fxcpfyscju) = itrytcgorf zjunqzngzw (rtzvecqjja ) View more | Positive | 25 May 2011 | ||
NO-donators (Arginine hydrochloride and L-Arginine aspartate) | mgdsmehqch(fxcpfyscju) = zkdgklpaqz zjunqzngzw (rtzvecqjja ) | ||||||
Not Applicable | 62 | paqclwqzit(wbdspmhics) = zstphgznxl wrmkxdwexf (hjiavjoklw ) View more | - | 26 Aug 2018 | |||
l-arginine aspartate | paqclwqzit(wbdspmhics) = bqpyknmwcd wrmkxdwexf (hjiavjoklw ) View more | ||||||
Not Applicable | 42 | L-Arginine aspartate + standard treatment | (aruseucied) = voxxldrpdn okepufkcss (shpdozuyxr ) | Positive | 10 Jun 2015 | ||
Standard treatment | (aruseucied) = bppqupdghx okepufkcss (shpdozuyxr ) |